Weight Loss Clinic in Chattanooga: Physician-Led GLP-1 Care












Paul Miranda, MD
Board-Certified in Family Medicine · Emergency Physician · Obesity Medicine Association member

I’m an emergency and Family Medicine physician in Chattanooga, Tennessee, and founder of Summit Metabolic Health. I read every patient chart personally. This article reports on a topic patients keep asking about — it is education, not an endorsement.

Medically reviewed by Paul Miranda, MD

If you’re searching “weight loss clinic Chattanooga,” you’re probably choosing between two very different things wearing the same label. One is a national telehealth brand — an app, a questionnaire, a subscription. The other is a physician who actually reads your chart. I’m Dr. Paul Miranda, a board-certified ER physician here in Chattanooga, and I built Summit Metabolic Health because that difference matters more than most people realize until they’ve already paid for the wrong one.

“Physician-led” gets used loosely. Here’s the honest version: at Summit, I personally review every chart. Not a questionnaire routed through software. Not a rotating queue of nurse practitioners you’ll never speak to twice.

The national telehealth weight-loss brands — Ro, Hims, Henry Meds, Found — were built to move volume. That’s not an insult; it’s the business model. An intake form gets scored, a protocol gets applied, and a prescriber signs off on a large batch of near-identical cases. For a lot of straightforward prescriptions, that works fine. For a medication that requires dose titration, side-effect management, and judgment calls about your specific history, it’s a different standard of care than a physician sitting with your actual labs and your actual story.

That’s the entire reason I read every chart myself. A checkbox you click yourself is not the same as a physician reviewing your actual history.

Before you decide who prescribes it, you should know what the medication itself does — in the actual trials, not the marketing copy.

In STEP 1 (Wilding et al., NEJM 2021), semaglutide 2.4 mg produced a mean body-weight reduction of 14.9% at 68 weeks, versus 2.6% with placebo. In plain terms: on average, a person on semaglutide lost roughly six times more weight than a person on placebo, over about 16 months.

In SURMOUNT-1 (Jastreboff et al., NEJM 2022), tirzepatide produced weight loss up to 20.9% at the highest dose (15 mg) at 72 weeks. Read that sentence carefully: these are group averages from a clinical trial population. They are not a promise about you.

Both medications work by quieting what patients describe as “food noise” — the constant background hum of thinking about your next meal. You did not fail every diet because you lacked willpower. These medications work on the biology of appetite and satiety. That’s not a character upgrade — it’s medicine, and it’s why the numbers above are real and repeatable when the drug is dosed and monitored correctly.

Note: figures above are stated as published in the cited trials; verify against NEJM directly before this post is published.

Here’s the honest answer to “what actually happens”: you come in — in person, here in Chattanooga, not just on a video call — I review your history and labs myself, and we talk through what’s realistic for you specifically. Not a generic plan. Not a default dose.

From there: custom-dosed compounded semaglutide or tirzepatide, a titration schedule built around how you tolerate it, and a direct line to me — not a support ticket — when side effects show up during dose escalation, which is when most people need real oversight and get the least of it. I tell patients plainly: do not judge the medication by week one. Escalation is where the GI side effects concentrate, and it’s exactly where a telehealth mill’s incentive to move fast works against you.

Both drugs work on the same core mechanism — GLP-1 receptor activity that slows gastric emptying and reduces appetite — but tirzepatide adds a second pathway (GIP) that, in the trial data above, correlates with a larger average effect size. That doesn’t automatically make it the right choice for you.

The honest answer depends on what we’re solving for: your GI tolerance, your history, your cost sensitivity, and how your body actually responds once we start — which we watch closely, because average trial numbers describe a population, not a person. This is exactly where physician oversight earns its keep. A protocol picks a drug off a flowchart. A physician picks a drug for you.

Here’s a question almost no program answers honestly: what does this cost after the first few months?

A lot of the national telehealth platforms lead with an attractive introductory rate, then the price moves once the promotional window ends. That’s a legitimate business decision on their end — but it means the number that got you to sign up is not the number you’ll be paying at month six. If you’re comparing options, ask every program the same question: what’s the price in month one, and what’s the price in month twelve? Get it in writing.

At Summit, custom-dosed compounded GLP-1 therapy runs $175–225/month, transparently, with no introductory-rate cliff. The goal isn’t to hook you on a low number and raise it once you’re committed — it’s to build a program you can actually stay on, priced the same way in month twelve as month one. The goal is your long-term result, not your long-term billing.

You can buy semaglutide or tirzepatide from a lot of places. What’s hard to find — here in Chattanooga or anywhere — is a board-certified physician who reads your chart, picks the medication with you, adjusts your dose to your tolerance, and plans for the day you no longer need it.

As an ER physician, I see what happens on the other end of unsupervised or under-supervised GLP-1 use — patients who never got real dose-escalation guidance, never had anyone check in when side effects hit, and ended up in my ER instead of my clinic. A national app has no incentive to know your name. A local, physician-led practice does, because I’ll see you again next month, and I’d rather see you at goal than see you in triage.

There’s also a practical piece nobody advertises: in-person visits mean an actual exam, not just a self-reported weight and a symptom checklist. Blood pressure, heart rate, injection-site checks, a real conversation about what’s changed since your last visit — that’s harder to fake past and harder to miss when something’s off. A telehealth app optimized for volume isn’t set up to catch it. A local clinic built around one physician is.

This isn’t a program for someone who wants a script mailed to them with no questions asked — and I’d tell you that honestly in a consult, not after you’ve already paid. It’s for someone who wants a physician actually managing the medication: the dose, the side effects, the labs, and the exit plan once you’re at goal. If that’s not what you’re looking for, a national telehealth app will probably feel faster. Faster isn’t always better when the thing you’re managing is your own biology.

You don’t have to guess who’s actually reading your chart. Come in, talk to me directly, and get a plan built around your history — not a protocol built around volume.

Apply at summitmetabolichealth.com/apply

📞 (423) 407-7837 · ✉️ info@summitmetabolic.health 📍 200 W MLK Blvd Ste 1000, Chattanooga, TN 37402


This article is for general educational purposes only and is not medical advice. GLP-1 medications require evaluation and ongoing monitoring by a licensed physician. Individual results vary — the trial figures cited above are group averages, not a guarantee. Please consult Summit Metabolic Health or your own clinician before starting any treatment.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *